Show simple item record

dc.contributor.authorHiligsmann, Mickaël
dc.contributor.authorDellaert, Benedict G
dc.contributor.authorDirksen, Carmen D
dc.contributor.authorWatson, Verity
dc.contributor.authorBours, Sandrine
dc.contributor.authorGoemaere, Stefan
dc.contributor.authorReginster, Jean-Yves
dc.contributor.authorRoux, Christian
dc.contributor.authorMcGowan, Bernie
dc.contributor.authorSilke, Carmel
dc.contributor.authorWhelan, Bryan
dc.contributor.authorDiez-Perez, Adolfo
dc.contributor.authorTorres, Elisa
dc.contributor.authorPapadakis, Georgios
dc.contributor.authorRizzoli, Rene
dc.contributor.authorCooper, Cyrus
dc.contributor.authorPearson, Gill
dc.contributor.authorBoonen, Annelies
dc.date.accessioned2018-04-06T23:02:38Z
dc.date.available2018-04-06T23:02:38Z
dc.date.issued2017-07
dc.identifier.citationHiligsmann , M , Dellaert , B G , Dirksen , C D , Watson , V , Bours , S , Goemaere , S , Reginster , J-Y , Roux , C , McGowan , B , Silke , C , Whelan , B , Diez-Perez , A , Torres , E , Papadakis , G , Rizzoli , R , Cooper , C , Pearson , G & Boonen , A 2017 , ' Patients’ preferences for anti-osteoporosis drug treatment : a cross-European discrete-choice experiment ' Rheumatology , vol. 56 , no. 7 , pp. 1167-1176 . https://doi.org/10.1093/rheumatology/kex071en
dc.identifier.issn1462-0324
dc.identifier.otherPURE: 79618909
dc.identifier.otherPURE UUID: 62886838-9d71-4af4-97d1-b4acb2f51cf3
dc.identifier.otherScopus: 85021770002
dc.identifier.urihttp://hdl.handle.net/2164/10298
dc.descriptionAcknowledgements We would like to thank all participating centres: the Unit for Osteoporosis and Metabolic Bone from Ghent University Hospital (Belgium); the University Center for Investigation in Bone and Articular Cartilage Metabolism in Liege (Belgium); the Fracture Clinic of the Maastricht University Medical Center (Netherlands); the Bone Unit of Paris Descartes University, Paris (France); The North Western Rheumatology Unit, Our Lady’s Hospital, Manorhamilton and the Sligo University Hospital (Ireland); the Musculoskeletal Research Unit and RETICEF from the Universitat Auto` noma de Barcelona (Spain); the Division of Bone Diseases from the Geneva University Hospitals (Switzerland); the MRC Lifecourse Epidemiology Unit from the University of Southampton (UK) for helping us in data collection; Ed Porquie, our patient partner; Wafa Ben Sedrine, Ivette Essers and Wilco Tilburgs for data entry; and all the patients for their participation. Funding This work was supported by Amgen. The funding agreement between Maastricht University and Amgen ensured the authors’ independence in designing the study (including selection of attributes and levels), interpreting the data, and writing and publishing the report. Other participating centres were compensated by Maastricht University for their participation in the study.en
dc.format.extent10en
dc.language.isoeng
dc.relation.ispartofRheumatologyen
dc.rightsThis is a pre-copyedited, author-produced version of an article accepted for publication in Rheumatology following peer review. The version of record Mickaël Hiligsmann, Benedict G. Dellaert, Carmen D. Dirksen, Verity Watson, Sandrine Bours, Stefan Goemaere, Jean-Yves Reginster, Christian Roux, Bernie McGowan, Carmel Silke, Bryan Whelan, Adolfo Diez-Perez, Elisa Torres, Georgios Papadakis, Rene Rizzoli, Cyrus Cooper, Gill Pearson, Annelies Boonen; Patients’ preferences for anti-osteoporosis drug treatment: a cross-European discrete choice experiment. Rheumatology (Oxford) 2017 kex071. is available online at: https://doi.org/10.1093/rheumatology/kex071.en
dc.subjectCross-Country Comparisonen
dc.subjectdiscrete choice experimenten
dc.subjectdrug treatmenten
dc.subjectosteoperosisen
dc.subjectpatientsen
dc.subjectpreferencesen
dc.subjectR Medicineen
dc.subject.lccRen
dc.titlePatients’ preferences for anti-osteoporosis drug treatment : a cross-European discrete-choice experimenten
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen, Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen, Health Economics Research Uniten
dc.contributor.institutionUniversity of Aberdeen, Other Applied Health Sciencesen
dc.description.statusPeer revieweden
dc.description.versionPostprinten
dc.description.versionPostprinten
dc.description.versionPostprinten
dc.identifier.doihttps://doi.org/10.1093/rheumatology/kex071
dc.date.embargoedUntil06-04-20


Files in this item

Thumbnail
Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record